Row
M
MNPRAI Stock Diagnostic Report
Form 4 Monopar Therapeutics Inc For: 2 July
[MISTRAL] Monpar Therapeutics had a minimal impact on its stock price following the news that it submitted Form 4 on July 2.
View Source Article ↗AI CATALYST SCORE30 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
MNPR Analysis History (Last 30 Days)